rs118203891
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM2PP5
Variant has been reported in ClinVar as Pathogenic (no stars).
Frequency
Consequence
stop_lost
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TRNY | unassigned_transcript_4798 | c.18A>G | p.Ter6Trpext*? | stop_lost | Exon 1 of 1 | |||
COX1 | unassigned_transcript_4799 | c.-30T>C | upstream_gene_variant | |||||
TRNN | unassigned_transcript_4796 | c.-145A>G | upstream_gene_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|
Frequencies
GnomAD4 exome Cov.: 0
Mitomap
ClinVar
Submissions by phenotype
Exercise intolerance and complex III deficiency, somatic Pathogenic:1
- -
Mitochondrial disease Uncertain:1
The m.5874T>C variant in MT-TY has been reported in one individual with primary mitochondrial disease to date (PMIDs: 6095966, 11071502). This woman had exercise intolerance onset in childhood, muscle weakness, ptosis, and ragged red fibers on muscle biopsy. The variant was present at 89% heteroplasmy in muscle and was absent in blood. It was also absent in blood from her healthy mother and siblings, however technology at the time would not have reliably detected presence of the variant at low heteroplasmy levels. There are no other individuals with this variant reported to our knowledge. This variant is absent in the GenBank dataset, Helix dataset, and gnomAD v3.1.2 (PM2_supporting). In silico predictors are conflicting as the computational predictor MitoTIP suggests this variant is benign (38.9 percentile) but HmtVAR predicts it to be deleterious with a score of 0.65. Single fiber testing showed higher levels of the variant in COX-negative fibers (92.3±6.7%; n=12) than in COX-positive fibers (29.9±11.8%; n=12; p<0.000001; PS3_supporting, PMID: 11071502). In summary, this variant meets criteria to be classified as uncertain significance for primary mitochondrial disease inherited in a mitochondrial manner. This classification was approved by the NICHD/NINDS U24 ClinGen Mitochondrial Disease Variant Curation Expert Panel on June 10, 2024. Mitochondrial DNA-specific ACMG/AMP criteria applied (PMID: 32906214): PS3_supporting, PM2_supporting. -
not provided Other:1
GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at